Eureka Therapeutics
Emeryville · Founded 2006
About Eureka Therapeutics
Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. They have developed E-ALPHA into one of the world’s largest human-derived antibody phage libraries to generate target-specific antibodies, including T cell receptor-mimic antibodies against intracellular targets.
Company Facts
- Founded: 2006
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $139.5M
- Funding stage: Late Stage Venture
- Last round: Grant (Jun 2023)
- Website: https://www.eurekatherapeutics.com
- Phone: +1 510 654 7045
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/eureka-therapeutics-41956 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.